Woodside Energy has deployed around 50 AI agents in production to augment operations across its LNG plants and enterprise workflows. The company leverages years of investment in operational data and predictive analytics, with notable solutions including the Startup Advisor, an AI copilot that guides operators through complex LNG plant startups by analyzing historical data and providing real-time insights, and maintenance intelligence, which recommends optimal maintenance timing and has demonstrated a 15% reduction in maintenance hours over five years on a pilot asset. Woodside follows a 'think big, prototype small, scale fast' approach and maintains strong governance through a structured AI assessment process and an AI council. The company collaborates with Infosys as its managed service provider to support scaling and aims ultimately for an autonomous enterprise where agentic systems deeply interact with core workflows.
Australian startup Springboards has released Flint, a large language model fine-tuned from Alibaba's Qwen 3 to generate more varied responses. The model counters the tendency of mainstream LLMs to produce predictable, homogeneous outputs, such as always responding '7' to a random number prompt or recycling similar metaphors. Flint is trained to identify specific points in its output where injecting randomness yields diversity without incoherence. It is integrated into Springboards' creative brainstorming tool, targeting professionals in advertising and marketing. Early tests show Flint offering divergent ideas where other models converge, though it remains a prototype prone to errors when pushed too far.
Anthropic announced Claude Science, a new flagship product for scientific research that can autonomously write and execute code on computer clusters, with a focus on computational biology and drug discovery. It is available to all paid Claude subscribers and was demonstrated identifying drug candidates for phenylketonuria. The product emphasizes reproducibility and integrates with genetics and chemistry tools. Anthropic will also use Claude Science to pursue its own research into drugs for rare, neglected diseases. The launch positions it alongside Claude Code and Claude Cowork as a major commercial offering, targeting pharmaceutical and biotech firms.